Frequency of Autoimmune Diseases in Myasthenia Gravis: A Systematic Review

REFERENCES

• Al-Moallem, M. A., Alkali, N. H., Hakami, M. A., & Zaidan, R. M. (2008). Myasthenia gravis: Presentation and outcome in 104 patients managed in a single institution. Annals of Saudi Medicine, 28, 341–345.
   PubMed Web of Science ®Google Scholar
• Bache, I., Nielsen, N. M., Rostgaard, K., Tommerup, N., & Frisch, M. (2007). Autoimmune diseases in a Danish cohort of 4,866 carriers of constitutional structural chromosomal rearrangements. Arthritis and Rheumatism, 56, 2402–2409.
   PubMedGoogle Scholar
• Beekman, R., Kuks, J. B., & Oosterhuis, H. J. (1997). Myasthenia gravis: Diagnosis and follow-up of 100 consecutive patients. Journal of Neurology, 244, 112–118.
   PubMedGoogle Scholar
• Chmura Kraemer, H., Periyakoil, V. S., & Noda, A. (2002). Kappa coefficients in medical research. Statistics in Medicine, 21, 2109–2129.
   PubMed Web of Science ®Google Scholar
• Christensen, P. B., Jensen, T. S., Tsiropoulos, I., Sorensen, T., Kjaer, M., Hojer-Pedersen, E., (1995). Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurologica Scandinavica, 91, 192–195.
   PubMed Web of Science ®Google Scholar
• Christensen, P. B., Jensen, T. S., Tsiropoulos, I., Sorensen, T., Kjaer, M., Hojer-Pedersen, E., (1993). Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology, 43, 1779–1783.
   PubMedGoogle Scholar
• Citterio, A., Beghi, E., Millul, A., Evoli, A., Mantegazza, R., Antozzi, C., (2009). Risk factors for tumor occurrence in patients with myasthenia gravis. Journal of Neurology, 256, 1221–1227.
   PubMedGoogle Scholar
• Cooper, G. S., Bynum, M. L., & Somers, E. C. (2009). Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. Journal of Autoimmunity, 33, 197–207.
   PubMed Web of Science ®Google Scholar
• Cooper, G. S., & Stroehla, B. C. (2003). The epidemiology of autoimmune diseases. Autoimmunity Review, 2, 119–125.
   PubMed Web of Science ®Google Scholar
• D’Alessandro, R., Granieri, E., Benassi, G., Tola, M. R., Casmiro, M., Mazzanti, B., (1991). Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara, Italy. Acta Neurologica Scandinavica, 83, 83–88.
   PubMedGoogle Scholar
• Eaton, W. W., Rose, N. R., Kalaydjian, A., Pedersen, M. G., & Mortensen, P. B. (2007). Epidemiology of autoimmune diseases in Denmark. Journal of Autoimmunity, 29, 1–9.
   PubMed Web of Science ®Google Scholar
• Goldman, M., Herode, A., Borenstein, S., & Zanen, A. (1984). Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis. Arthritis and Rheumatism, 27, 701–703.
   PubMedGoogle Scholar
• Goulon, M., Estournet, B., & Tulliez, M. (1980). Myasthenia gravis and associated diseases. International Journal of Neurology, 14, 61–72.
   PubMedGoogle Scholar
• Grimes, D. A., & Schulz, K. F. (2002). Bias and causal associations in observational research. Lancet, 359, 248–252.
   PubMed Web of Science ®Google Scholar
• Grob, D., Brunner, N., Namba, T., & Pagala, M. (2008). Lifetime course of myasthenia gravis. Muscle & Nerve, 37, 141–149.
   PubMed Web of Science ®Google Scholar
• Guidetti, D., Sabadini, R., Bondavalli, M., Cavalletti, S., Lodesani, M., Mantegazza, R., (1998). Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. European Journal of Epidemiology, 14, 381–387.
   PubMedGoogle Scholar
• Hackett, M. L., Yapa, C., Parag, V., & Anderson, C. S. (2005). Frequency of depression after stroke: A systematic review of observational studies. Stroke, 36, 1330–1340.
   PubMed Web of Science ®Google Scholar
• Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. (1997). Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clinical Immunology and Immunopathology, 84, 223–243.
   PubMedGoogle Scholar
• Kanazawa, M., Shimohata, T., Tanaka, K., & Nishizawa, M. (2007). Clinical features of patients with myasthenia gravis associated with autoimmune diseases. European Journal of Neurology, 14, 1403–1404.
   PubMed Web of Science ®Google Scholar
• Lavrnic, D., Jarebinski, M., Rakocevic-Stojanovic, V., Stevic, Z., Lavrnic, S., Pavlovic, S., (1999). Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983–1992). Acta Neurologica Scandinavica, 100, 168–174.
   PubMedGoogle Scholar
• Lennon, V. A., Lindstrom, J. M., & Seybold, M. E. (1975). Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs. Journal of Experimental Medicine, 141, 1365–1375.
   PubMed Web of Science ®Google Scholar
• Levin, N., Abramsky, O., Lossos, A., Karussis, D., Siegal, T., Argov, Z., (2005). Extrathymic malignancies in patients with myasthenia gravis. Journal of The Neurological Sciences, 237, 39–43.
   PubMed Web of Science ®Google Scholar
• Lew, W., Pai, M., Oxlade, O., Martin, D., & Menzies, D. (2008). Initial drug resistance and tuberculosis treatment outcomes: Systematic review and meta-analysis. Annals of Internal Medicine, 149, 123–134.
   PubMed Web of Science ®Google Scholar
• Marino, M., Ricciardi, R., Pinchera, A., Barbesino, G., Manetti, L., Chiovato, L., (1997). Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. Journal of Clinical Endocrinology and Metabolism, 82, 438–443.
   PubMed Web of Science ®Google Scholar
• Matsui, N., Nakane, S., Nakagawa, Y., Kondo, K., Mitsui, T., Matsumoto, T., (2009). Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. Journal of Neurology, Neurosurgery and Psychiatry, 80, 1168–1171.
   PubMed Web of Science ®Google Scholar
• Mellemkjaer, L., Pfeiffer, R. M., Engels, E. A., Gridley, G., Wheeler, W., Hemminki, K., (2008). Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis and Rheumatism, 58, 657–666.
   PubMed Web of Science ®Google Scholar
• Oopik, M., Kaasik, A. E., & Jakobsen, J. (2003). A population-based epidemiological study on myasthenia gravis in Estonia. Journal of Neurology Neurosurgery and Psychiatry, 74, 1638–1643.
   PubMedGoogle Scholar
• Oosterhuis, H. J. (1981a). Myasthenia gravis. A survey. Clinical Neurology and Neurosurgery, 83, 105–135.
   PubMedGoogle Scholar
• Oosterhuis, H. J. (1981b). Observations of the natural history of myasthenia gravis and the effect of thymectomy. Annals of the New York Academy of Sciences, 377, 678–690.
   PubMed Web of Science ®Google Scholar
• Oosterhuis, H. J. (1989). The natural course of myasthenia gravis: A long-term follow-up study. Journal of Neurology, Neurosurgery and Psychiatry, 52, 1121–1127.
   PubMed Web of Science ®Google Scholar
• Oosterhuis, H. J., & de Haas, W. H. (1968). Rheumatic diseases in patients with myasthenia gravis. An epidemiological and clinical investigation. Acta Neurologica Scandinavica, 44, 219–227.
   PubMed Web of Science ®Google Scholar
• Patrick, J., & Lindstrom, J. (1973). Autoimmune response to acetylcholine receptor. Science, 180, 871–872.
   PubMed Web of Science ®Google Scholar
• Pendlebury, S. T., & Rothwell, P. M. (2009). Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. Lancet Neurology, 8, 1006–1018.
   PubMed Web of Science ®Google Scholar
• Potagas, C., Dellatolas, G., Tavernarakis, A., Molari, H., Mourtzouhou, P., Koutra, H., (2004). Myasthenia gravis: Changes observed in a 30-year retrospective clinical study of a hospital-based population. Journal of Neurology, 251, 116–117.
   PubMedGoogle Scholar
• Poulas, K., Tsibri, E., Kokla, A., Papanastasiou, D., Tsouloufis, T., Marinou, M., (2001). Epidemiology of seropositive myasthenia gravis in Greece. Journal of Neurology, Neurosurgery and Psychiatry, 71, 352–356.
   PubMed Web of Science ®Google Scholar
• Ramagopalan, S. V., Dyment, D. A., Valdar, W., Herrera, B. M., Criscuoli, M., Yee, I. M., (2007). Autoimmune disease in families with multiple sclerosis: A population-based study. Lancet Neurology, 6, 604–610.
   PubMed Web of Science ®Google Scholar
• Rastenyte, D., Vaitkus, A., Neverauskas, R., & Pauza, V. (2002). Demographic and clinical characteristics of patients with myasthenia gravis. Medicina (Kaunas), 38, 611–616.
   PubMedGoogle Scholar
• Robertson, N. P., Deans, J., & Compston, D. A. (1998). Myasthenia gravis: A population-based epidemiological study in Cambridgeshire, England. Journal of Neurology, Neurosurgery and Psychiatry, 65, 492–496.
   PubMed Web of Science ®Google Scholar
• Roxanis, I., Micklem, K., & Willcox, N. (2001). True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: Implications for immunopathogenesis. Journal of Neuroimmunology, 112, 163–173.
   PubMedGoogle Scholar
• Simpson, J. A. (1960). Myasthenia gravis, a new hypothesis. Scottish Medical Journal, 5, 419–436.
   Google Scholar
• Somers, E. C., Thomas, S. L., Smeeth, L., & Hall, A. J. (2009). Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? American Journal of Epidemiology, 169, 749–755.
   PubMedGoogle Scholar
• Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., (2000). Meta-analysis of observational studies in epidemiology: A proposal for reporting meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, 283, 2008–2012.
   PubMed Web of Science ®Google Scholar
• Suzuki, S., Shimoda, M., Kawamura, M., Sato, H., Nogawa, S., Tanaka, K., (2005). Myasthenia gravis accompanied by alopecia areata: Clinical and immunogenetic aspects. European Journal of Neurology, 12, 566–570.
   PubMed Web of Science ®Google Scholar
• Tellez-Zenteno, J. F., Cardenas, G., Estanol, B., Garcia-Ramos, G., & Weder-Cisneros, N. (2004). Associated conditions in myasthenia gravis: Response to thymectomy. European Journal of Neurology, 11, 767–773.
   PubMed Web of Science ®Google Scholar
• Toth, C., McDonald, D., Oger, J., & Brownell, K. (2006). Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurologica Scandinavica, 114, 124–132.
   PubMed Web of Science ®Google Scholar
• Tsinzerling, N., Lefvert, A. K., Matell, G., & Pirskanen-Matell, R. (2007). Myasthenia gravis: A long-term follow-up study of Swedish patients with specific reference to thymic histology. Journal of Neurology, Neurosurgery and Psychiatry, 78, 1109–1112.
   PubMed Web of Science ®Google Scholar
• Yu, Y. L., Hawkins, B. R., Ip, M. S., Wong, V., & Woo, E. (1992). Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurologica Scandinavica, 86, 113– 119.
   PubMedGoogle Scholar